Nordson Corporation (NASDAQ:NDSN) Q1 2024 Earnings Call Transcript

That has changed. We no longer get blanket orders. Instead we get more regular book and ship kind of business. So that has changed. So, we’re still working through this. But the more interesting part is we have some pretty nice growth in patient care. We have some pretty good growth in surgical applications, and so that’s where we’re beginning to see some pretty good order entry and pretty good shipment. Nothing about biopharma has fundamentally changed. Single use plastics, transition from stainless steel to plastic, increased amount of biopharmaceuticals, all long term trends still intact, still favorable for the business. I’d love to be able to tell you when exactly this inflects. I just don’t know.

Operator: We have no further questions in our queue at this time. I will now turn the call back over to Naga for closing remarks.

Operator: Our strong operating performance reflects the strength of our diversified end markets, close to the customer model, differentiated precision technology products and rigorous implementation of NBS Next growth framework. Again, I want to thank Nordson’s employees for their commitment, which makes these results possible. And continued deployment of the Ascend strategy positions us well for long term growth. Thank you for your time and attention on today’s call. Have a great day.

Operator: This concludes today’s conference call. Thank you for your participation and you may now disconnect.